We are live on ! Find out more
Morgan Stanley

Morgan Stanley Portfolio holdings

AUM $1.66T
1-Year Est. Return 25.57%
 

Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.

This Fund
S&P 500
This Quarter Est. Return
+3.31%
1 Year Est. Return
+25.57%
3 Year Est. Return
+85.95%
5 Year Est. Return
+96.01%
10 Year Est. Return
+466.5%
AUM
$1.67T
AUM Growth
+$23.3B
Cap. Flow
-$2.36B
Cap. Flow %
-0.14%
Top 10 Hldgs %
22.15%
Holding
8,587
New
427
Increased
3,946
Reduced
2,962
Closed
384

Sector Composition

Rank Sector Weight
1 Technology 22.44%
2 Financials 11.14%
3 Consumer Discretionary 8.06%
4 Healthcare 8.02%
5 Communication Services 7.66%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NINE
7151
DELISTED
Nine Energy Service
NINE
$1.05K ﹤0.01%
3,048
-1
-0%
RDTL
7152
GraniteShares 2x Long RDDT Daily ETF
RDTL
$56.8M
$1.05K ﹤0.01%
+21
New +$940
RPTX
7153
DELISTED
Repare Therapeutics
RPTX
$1.05K ﹤0.01%
404
-6,334
-94% -$12.8K
SIMA
7154
SIM Acquisition Corp I
SIMA
$89.8M
$1.05K ﹤0.01%
99
+15
+18% +$158
LPAA
7155
Launch One Acquisition Corp
LPAA
$1.05K ﹤0.01%
99
+15
+18% +$158
CENN icon
7156
Cenntro
CENN
$8.26M
$1.04K ﹤0.01%
128
-296
-70% -$3.79K
LPBB
7157
Launch Two Acquisition Corp
LPBB
$310M
$1.04K ﹤0.01%
99
+15
+18% +$157
DRDB
7158
Roman DBDR Acquisition Corp II
DRDB
$326M
$1.03K ﹤0.01%
99
+15
+18% +$156
LYRA
7159
DELISTED
LYRA THERAPEUTICS INC
LYRA
$1.03K ﹤0.01%
334
-943
-74% -$4.69K
LOKV
7160
DELISTED
Live Oak Acquisition Corp V
LOKV
$1.02K ﹤0.01%
99
+15
+18% +$154
PRPL icon
7161
Purple Innovation
PRPL
$30.2M
$1.02K ﹤0.01%
59
-1,280
-96% -$25.5K
WENN
7162
Wen Acquisition Corp
WENN
$389M
$1.01K ﹤0.01%
100
+80
+400% +$814
XTLB
7163
XTL Biopharmaceuticals
XTLB
$6.71M
$1.01K ﹤0.01%
435
-2,068
-83% -$8.37K
IVDA icon
7164
Iveda Solutions
IVDA
$4.69M
$1.01K ﹤0.01%
+1,200
New +$1.34K
KEMX icon
7165
KraneShares MSCI Emerging Markets Ex China Index ETF
KEMX
$130M
$996 ﹤0.01%
26
+25
+2,500% +$911
BYAH
7166
Park Ha Biological Technology Co
BYAH
$2.67M
$996 ﹤0.01%
16
+1
+7% +$121
ZJK
7167
ZJK Industrial Co
ZJK
$113M
$992 ﹤0.01%
496
-10,839
-96% -$28.2K
POLE
7168
Andretti Acquisition Corp II
POLE
$319M
$988 ﹤0.01%
94
+15
+19% +$158
FERA
7169
Fifth Era Acquisition Corp I
FERA
$327M
$988 ﹤0.01%
96
+16
+20% +$165
ELBM
7170
Electra Battery Materials
ELBM
$64.1M
$978 ﹤0.01%
1,222
-71,485
-98% -$95K
MLAC
7171
DELISTED
Mountain Lake Acquisition Corp
MLAC
$978 ﹤0.01%
94
+15
+19% +$156
CANE icon
7172
Teucrium Sugar Fund
CANE
$53.2M
$976 ﹤0.01%
100
-2,144
-96% -$20.8K
AIM
7173
AIM ImmunoTech
AIM
$7.05M
$976 ﹤0.01%
865
+1
+0.1% +$2
CUB
7174
Lionheart Holdings
CUB
$285M
$967 ﹤0.01%
91
+15
+20% +$159
MRLN
7175
Merlin Inc
MRLN
$408M
$965 ﹤0.01%
90
+17
+23% +$185

Similar funds

Morgan Stanley's Q4 2025 Portfolio in Review

As of Q4 2025, Morgan Stanley held 8,587 positions worth $1.67T, up 1.4% from $1.65T the previous quarter. Its ten largest holdings account for 22% of the portfolio.

Morgan Stanley's Q4 2025 filing shows 427 new, 3,946 increased, 2,962 reduced and 384 closed positions. Its largest new stake was Medline Inc: 15,162,060 shares worth $637M. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $7.66B.

By sector, the portfolio is most concentrated in Technology at 22% of assets, down from 23% a quarter earlier, followed by Financials and Consumer Discretionary.

  • Morgan Stanley's largest Q4 2025 buy was Medline Inc: 15,162,060 shares worth $637M.
  • Morgan Stanley added most to Vanguard FTSE Developed Markets ETF in Q4 2025, an estimated $1.69B increase.
  • Morgan Stanley's biggest Q4 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $7.66B.
  • Morgan Stanley fully exited Mr. Cooper in Q4 2025, selling an estimated $312M.
  • Morgan Stanley's ten largest holdings make up 22% of its $1.67T portfolio in Q4 2025.
  • Morgan Stanley opened 427 new positions and closed 384 in Q4 2025.
  • Morgan Stanley's portfolio value rose 1.4% quarter-over-quarter to $1.67T.

Based on Morgan Stanley's 13F filing for Q4 2025, filed 13 Feb 2026.